Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients
Lisa Rice(Moderna Therapeutics (United States)), Robert Lafyatis(University of Pittsburgh Medical Center)
Cited by 343
Related Papers
Myofibroblast transcriptome indicates SFRP2hi fibroblast progenitors in systemic sclerosis skin
|Nature Communications|2021|257